Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Statements of Cash Flows

v3.22.2.2
Unaudited Condensed Statements of Cash Flows - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash Flows from Operating Activities:              
Net income (loss) $ 3,439,654 $ 7,825,776 $ 837,388 $ 2,302,546 $ 16,372,151 $ (192,195)  
Adjustments to reconcile net income (loss) to net cash used in operating activities:              
Interest income from investments held in Trust Account (2,238,508)   (6,381)   (2,957,940) (29,272)  
Financing costs—derivative warrant liabilities         0 634,480  
Change in fair value of derivative warrant liabilities (1,519,770)   (1,139,810)   (14,437,700) (1,139,810)  
Changes in operating assets and liabilities:              
Prepaid expenses         492,558 (1,002,480)  
Accounts payable         47,066 51,001  
Accrued expenses         7,500 32,375  
Net cash used in operating activities         (476,365) (1,645,901)  
Cash Flows from Investing Activities:              
Cash deposited in Trust Account         0 (495,909,080)  
Net cash used in investing activities         0 (495,909,080)  
Cash Flows from Financing Activities:              
Repayment of note payable to related party         0 (170,558)  
Proceeds received from initial public offering, gross         0 495,909,080  
Proceeds received from private placement         0 13,618,182  
Offering costs paid         (70,000) (10,366,024)  
Net cash (used in) provided by financing activities         (70,000) 498,990,680  
Net increase in cash         (546,365) 1,435,699  
Cash—beginning of the period   $ 1,260,014   $ 0 1,260,014 0 $ 0
Cash—end of the period 713,649   1,435,699   713,649 1,435,699 $ 1,260,014
Supplemental disclosure of noncash investing and financing activities:              
Offering costs included in accrued expenses 0   70,000   0 70,000  
Offering costs paid by related party under promissory note         0 129,005  
Reversal of accrued expenses         0 58,385  
Outstanding accounts payable balance paid by related party under note payable         0 37,500  
Deferred underwriting commissions $ 0   $ 17,356,818   0 17,356,818  
Remeasurement of Class A ordinary shares subject to possible redemption         $ 2,897,690 $ 38,349,497